Isis Biopolymer Finds $3M

Xconomy Boston — 

Isis Biopolymer, a Providence, RI-based developer of drug-delivery devices, has raised $3 million in equity financing, according to an SEC filing. The document does not list the investors in the round, and company CEO Emma Durand was not immediately available for comment this afternoon. The company says on its website that it was founded in 2006 and has developed a patch—embedded computer chips, thin-film batteries, and other technology—to deliver drugs through the skin.